Cite
HARVARD Citation
Wilding, J. et al. (n.d.). Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years. Diabetes, obesity & metabolism. 16 (2), pp. 124-136. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wilding, J. et al. (n.d.). Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years. Diabetes, obesity & metabolism. 16 (2), pp. 124-136. [Online].